Vivaldi Opportunities Fund Ár/értékesítés
Mi az Vivaldi Opportunities Fund Ár/értékesítés?
A Ár/értékesítés az Vivaldi Opportunities Fund - 11.15
Mi a Ár/értékesítés meghatározása?
Az ár / árbevétel arány a vállalat részvényeinek árbevételéhez képest.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Ár/értékesítés a Finance szektor a NYSE-on cégekben a Vivaldi Opportunities Fund -hoz képest
Mit csinál Vivaldi Opportunities Fund?
Vivaldi Opportunities Fund is a closed-end investment management company. It seeks to generate long-term returns with low sensitivity to traditional equity and fixed income indices. The company was founded on March 29, 2017 and is headquartered in Milwaukee, WI.
ár/értékesítés -hoz hasonló cégek Vivaldi Opportunities Fund
- Vision Marine Technologies nak Ár/értékesítés 11.13 van
- Haina Intelligent Equip Intl nak Ár/értékesítés 11.13 van
- Pacific Biosciences of California Inc nak Ár/értékesítés 11.13 van
- amalphi ag nak Ár/értékesítés 11.14 van
- Page Industries nak Ár/értékesítés 11.14 van
- Cymabay Therapeutics Inc nak Ár/értékesítés 11.15 van
- Vivaldi Opportunities Fund nak Ár/értékesítés 11.15 van
- Ad.Biotech. Dl ,0001 nak Ár/értékesítés 11.15 van
- East Coast Investment Grade Income Fund nak Ár/értékesítés 11.16 van
- Eastgroup Properties nak Ár/értékesítés 11.16 van
- Aberdeen Latin American Income Fund nak Ár/értékesítés 11.17 van
- Auto Trader plc nak Ár/értékesítés 11.18 van
- Pollen Street Secured Lending Plc nak Ár/értékesítés 11.18 van